- Science News
- Health
- Combating malaria through vaccines, antibody treatment and apoptotic pathway therapy
Combating malaria through vaccines, antibody treatment and apoptotic pathway therapy
Recent research published in Frontiers in Cellular and Infection Microbiology focuses on combating malaria through vaccines. In Parasite Carbohydrate Vaccines, by Jonnel A. Jaurigue and Peter H. Seeberger, examples, strategy and the status of carbohydrate antigen vaccines against malaria are reviewed. In Engineering of Genetically Arrested Parasites (GAPs) For a Precision Malaria Vaccine, Oriana Kreutzfeld, Katja Müller and Kai Matuschewski assess the most recent developments in GAP vaccine discovery.
Credit: Jaurigue JA and Seeberger PH (2017) Parasite Carbohydrate Vaccines. Front. Cell. Infect. Microbiol. 7:248. doi: 10.3389/fcimb.2017.00248
Read more research related to malaria in the recently launched Parasite and Host specialty section:
Evidencing the Role of Erythrocytic Apoptosis in Malarial Anemia
NF-κB-Like Signaling Pathway REL2 in Immune Defenses of the Malaria Vector Anopheles gambiae
Find out more about the new Section on Parasite and Host just launched in Frontiers in Cellular and Infection Microbiology and led by Chief Editors Jeroen Saeij and Stefan Kappe
Follow Frontiers in Cellular and Infection Microbiology on Twitter
For the latest research, subscribe to Article Alerts on Frontiers in Cellular and Infection Microbiology
Frontiers journals have some of the highest citation rates. Among the world’s 20 largest publishers in 2017, Frontiers ranks 4th most-cited with an average of 3.65 citations per article. In total, Frontiers articles have received more than 700,000 citations to date.